Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines (O2B)
NCT02563678Phase 1Unknown
- Sponsor
- Intermountain Health
- Start
- Apr 2015
- Primary completion
- Dec 2023
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Phase 1, open-label trial of hyperbaric oxygen therapy in Infection, carbon monoxide poisoning and traumatic brain injury (TBI), sponsored by Intermountain Health. Status: unknown.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
Infectioncarbon monoxide poisoningtraumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02563678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02563678.